| Vaccination against Clostridium difficile by Use of an Attenuated Salmonella enterica Serovar Typhimurium Vector (YS1646) Protects Mice from Lethal Challenge K Winter, L Xing, A Kassardjian, BJ Ward Infection and immunity 87 (8), 10.1128/iai. 00089-19, 2019 | 14 | 2019 |
| B cell targeting by molecular adjuvants for enhanced immunogenicity T Sicard, A Kassardjian, JP Julien Expert Review of Vaccines 19 (11), 1023-1039, 2020 | 9 | 2020 |
| Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein E Thai, R Murugan, Š Binter, CB Aschner, K Prieto, A Kassardjian, ... Cell Reports 42 (11), 2023 | 2 | 2023 |
| Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses A Kassardjian, E Sun, J Sookhoo, K Muthuraman, KF Boligan, ... Cell reports 42 (4), 2023 | 2 | 2023 |
| Humanization of pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework A Kassardjian, D Ivanochko, B Barber, A Jetha, JP Julien Preprints, 2024 | | 2024 |
| Sars-cov-2 constructs, vaccines, and methods JP Julien, A Kassardjian, B Barber US Patent App. 18/251,963, 2024 | | 2024 |
| A general platform for targeting MHC-II antigens via a single loop H Du, J Liu, KM Jude, X Yang, Y Li, B Bell, H Yang, A Kassardjian, ... bioRxiv, 2024 | | 2024 |
| Supplemental information Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses A Kassardjian, E Sun, J Sookhoo, K Muthuraman, KF Boligan, ... Cell Press, 2023 | | 2023 |
Jean-Philippe JulienScientist, Hospital for Sick Children Research InstituteVerified email at sickkids.ca
